Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesHematology/OncologyPacificSource Lung Tumor Ablation Coverage | OpenP…
    Ask Trek AI about this page
    CurrentPacificSource Community SolutionsPolicy N/A

    Ablative Treatments for Lung Tumors

    Customize your policy alerts

    Sign up for all pacificsourcecommunitysolutions policy alerts

    Know when pacificsourcecommunitysolutions releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and medical-necessity determinations for microwave ablation and cryosurgical ablation of lung tumors for PacificSource Commercial, Medicare, and Oregon Medicaid members in Idaho, Montana, Oregon, and Washington. Coverage is subject to prior authorization, applicable program-specific criteria, and the member's benefit plan.

    Policy Summary
    PayerPacificSource Community Solutions
    PolicyAblative Treatments for Lung Tumors
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateFebruary 1, 2022
    Next Review DateApril 1, 2027
    Key ActionObtain prior authorization and submit the lung tumor ablation service for medical-necessity review under the applicable Commercial, Medicare, or Medicaid criteria.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Ablative treatment modalities addressed
    3 cm or smallerMaximum tumor size for specified microwave ablation criteria

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    1 cmMinimum distance from specified critical structures for microwave ablation
    Prior authorization requiredAuthorization requirement
    4Applicable states
    All other indicationsOther indications classified as experimental, investigational, or unproven

    Covered Ablative Treatments

    Microwave ablation for isolated peripheral NSCLC

    Microwave ablation is medically necessary when ONE of the following criteria is met.

    Isolated peripheral NSCLC lesion(s)

    • Eligibility and tumor characteristics

      • Not a candidate for surgery or radiation: The member is not a candidate for surgery or radiation due to medical co-morbidities.
      • Tumor size and location

        • Curative-intent treatment appropriate: Surgical resection or radiation treatment with curative intent is considered appropriate based on stage of disease.
        • Distance from critical structures: The tumor is located at least 1 cm from the trachea, main bronchi, esophagus, aorta, aortic arch branches, pulmonary artery, and heart.≥ 1 cm from each listed structure

    Microwave ablation for metastatic lung lesions

    Microwave ablation is medically necessary when ONE of the following criteria is met.

    Metastatic lung lesion(s)

    • Metastatic lesion requirements

      • Preserve lung function or not a surgical candidate: Treatment is intended to preserve lung function when surgical resection or radiation treatment is likely to worsen pulmonary status, or the member is not considered a surgical candidate.
      • Tumor size: The tumor is 3 cm or smaller.≤ 3 cm
      • No extrapulmonary metastases: There is no evidence of extrapulmonary metastases.None

    Cryosurgical ablation for lung tumors

    Cryosurgical ablation to treat lung tumors is medically necessary when ONE of the following criteria is met.

    Cryosurgical ablation indications

    • Early-stage NSCLC: Non-small cell lung cancer is Stage I or node-negative Stage II.Stage I or node-negative Stage II
    • Palliation of central airway obstruction: The member requires palliation for a central airway-obstructing lesion.

    Oregon Medicaid criteria hierarchy

    Oregon Medicaid coverage follows the applicable criteria hierarchy and requires individual medical-necessity and medical-appropriateness review.

    Oregon Medicaid coverage hierarchy

    • Funded condition and service: The condition and service pair must be on a funded line of the HERC Prioritized List of Health Services.
    • Applicable guideline requirements: All relevant Guideline criteria must be met, including Guideline Note 174 and Excluded Services Guideline E2.
    • Individual review requirements

      • Medical necessity: The service must be medically necessary for the specific member.

    Medicare coverage

    Medicare follows CMS guidelines and criteria; when CMS criteria are absent, the Commercial clinical criteria apply.

    Medicare coverage criteria

    • CMS criteria available: Coverage is determined under applicable CMS guidelines and criteria.
    • CMS criteria absent: In the absence of applicable CMS guidelines and criteria, coverage and medical necessity are determined under the PacificSource Commercial clinical criteria for ablative treatments for lung tumors.

    For Oregon Medicaid, radiofrequency ablation and microwave ablation of lung tumors are identified under Excluded Services Guideline E2 as services for which there is insufficient evidence of effectiveness. Coverage determinations must also follow the applicable Oregon Medicaid criteria hierarchy, including funded-line requirements, relevant guideline criteria, and individual medical-necessity and medical-appropriateness review.

    Microwave ablation and cryosurgical ablation are considered experimental, investigational, or unproven for all other indications, except for liver tumors. Items on the experimental, investigational, or unproven list are subject to medical-necessity review under the applicable criteria hierarchy.

    Coding Information

    Coding InformationCPT
    31641Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser therapy, cryotherapy)
    32994Ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved in tumor extension, percutaneous, including imaging guidance when performance, unilateral; cryoablation
    32998Ablation therapy for reduction or eradication of one (1) or more pulmonary tumor(s), including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; radiofrequency
    32999Unlisted procedure, lungs and pleura

    Authorization and Coverage Actions

    Prior Authorization

    Submit prior authorization before treatment

    Obtain prior authorization before providing ablative treatment for a lung tumor. Submit the service for medical-necessity review under the applicable Commercial, Medicare, or Medicaid criteria.

    • Applicable CPT codes include 31641, 32994, 32998, and 32999.
    Denial Risk

    Verify the indication is covered

    Microwave ablation and cryosurgical ablation are considered experimental, investigational, or unproven for all other indications, except for liver tumors. Services outside the covered indications may be denied.

    • Covered lung-tumor indications must meet the applicable medical-necessity criteria.

    Clinical Background

    Surgical resection is the treatment of choice for primary non-small cell lung cancer and metastatic tumors in the lung. For members who are not surgical candidates, locoregional therapies such as microwave ablation or cryosurgical ablation may be treatment options in selected circumstances, including local tumor control or symptom palliation.

    Key Definitions

    Microwave Ablation (MWA)
    MethodUses microwave thermal energy to ablate localized tissue.
    Tissue effectCreates coagulation and necrosis of localized tissue.
    Potential applicationsMay be used to treat tumors, control local tumor growth, and palliate symptoms.
    Cryosurgical Ablation
    Also known asCryosurgery.
    MethodDestroys target cells by freezing tissue, most often through a probe inserted into the tumor.
    Coolant and ice formation
    Policy Summary
    PayerPacificSource Community Solutions
    PolicyAblative Treatments for Lung Tumors
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateFebruary 1, 2022
    Next Review DateApril 1, 2027
    Key ActionObtain prior authorization and submit the lung tumor ablation service for medical-necessity review under the applicable Commercial, Medicare, or Medicaid criteria.
    SourceLink
    On This Page
    Covered Ablative TreatmentsCoding InformationAuthorization and Coverage ActionsClinical BackgroundKey Definitions
  1. Distance from critical structures: The tumor is located at least 1 cm from the trachea, main bronchi, esophagus, aorta, aortic arch branches, pulmonary artery, and heart.≥ 1 cm from each listed structure
  2. Medical appropriateness:
    The service must be medically appropriate for the specific member.
    Denial Risk

    Confirm isolated NSCLC criteria before microwave ablation

    Microwave ablation for an isolated peripheral NSCLC lesion is not medically necessary when the member is a surgical candidate, the tumor exceeds 3 cm, curative-intent surgery or radiation is not appropriate based on disease stage, or the tumor is within 1 cm of a specified critical structure.

    • The member must not be a candidate for surgery or radiation because of medical co-morbidities.
    • The tumor must be 3 cm or smaller.
    • The tumor must be at least 1 cm from the trachea, main bronchi, esophagus, aorta, aortic arch branches, pulmonary artery, and heart.
    Denial Risk

    Confirm metastatic lesion criteria before treatment

    Microwave ablation for metastatic lung lesions is not medically necessary when treatment does not preserve lung function as required, the member is a surgical candidate, the tumor exceeds 3 cm, extrapulmonary metastases are present, or the tumor is within 1 cm of a specified critical structure.

    • Treatment must preserve lung function when surgery or radiation is likely to worsen pulmonary status, or the member must not be considered a surgical candidate.
    • There must be no evidence of extrapulmonary metastases.
    • The tumor must be at least 1 cm from the trachea, main bronchi, esophagus, aorta, aortic arch branches, pulmonary artery, and heart.
    Denial Risk

    Apply Oregon Medicaid exclusions and coverage hierarchy

    For Oregon Medicaid, microwave ablation of lung tumors is identified under Excluded Services Guideline E2 as a service for which there is insufficient evidence of effectiveness. Confirm that the condition and service pair is on a funded line of the HERC Prioritized List, applicable guideline requirements are met, and the service is medically necessary and appropriate for the specific member.

    • Apply the applicable hierarchy, including Guideline Note 174 and Excluded Services Guideline E2.
    • Additional coverage options for unfunded conditions and services are described in OAR 410-141-3820.
    • Services may be limited or excluded under OAR 410-141-3825 and OAR 410-120-1200.
    Coolant circulates through the probe, causing ice crystals to form around it.
    Potential applicationsMay destroy or shrink tumor tissue, control local tumor growth, prevent recurrence, palliate symptoms, and extend survival for certain tumors.
    Surgical Candidate
    ConditionA primary non-small cell lung cancer or metastatic tumor in the lung.
    Preferred treatmentSurgical resection is the treatment of choice.
    Clinical feasibilityThe member is considered a surgical candidate when surgical resection is clinically feasible; members who are not surgical candidates may be considered for locoregional therapies such as microwave ablation or cryosurgical ablation.